Bridgeway Capital Management, LLC Scopus Bio Pharma Inc. Transaction History

Bridgeway Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.36 - $0.74 $12,600 - $25,900	-35,000 Reduced 51.5%	32,966 $14,000
Q1 2022 May 16, 2022	SELL	$0.6 - $1.7 $15,600 - $44,200	-26,000 Reduced 27.67%	67,966 $47,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $4.28 $37,653 - $98,868	23,100 Added 32.6%	93,966 $154,000
Q3 2021 Nov 15, 2021	BUY	$4.0 - $6.99 $95,428 - $166,760	23,857 Added 50.75%	70,866 $294,000
Q1 2021 May 17, 2021	BUY	$7.94 - $14.87 $373,251 - $699,023	47,009 New	47,009 $397,000

Ticker SCPS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,094,300
Description
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.